GAPDH binding to TNF-α mRNA contributes to posttranscriptional repression in monocytes: A novel mechanism of communication between inflammation and metabolism

Journal of Immunology

Volumn 196, Issue 6, 2016, Pages 2541-2551

  Millet, Patrick ^a   Vachharajani, Vidula ^a   McPhail, Linda ^a   Yoza, Barbara ^a   McCall, Charles E ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR;

3' UNTRANSLATED REGION; ARTICLE; CELL LINE; CONTROLLED STUDY; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; GLYCOLYSIS; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INFLAMMATION; MACROPHAGE; METABOLISM; POLYSOME; POSTTRANSCRIPTIONAL REPRESSION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RNA IMMUNOPRECIPITATION; THP 1 CELL; TRANSCRIPTION REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; IMMUNOLOGY; MONOCYTE; REAL TIME POLYMERASE CHAIN REACTION; RNA PROCESSING; WESTERN BLOTTING;

BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE (PHOSPHORYLATING); GLYCOLYSIS; HUMANS; IMMUNOPRECIPITATION; INFLAMMATION; MONOCYTES; REAL-TIME POLYMERASE CHAIN REACTION; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84962625272     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1501345     Document Type: Article

References (61)

1. Cramer, T., Y. Yamanishi, B. E. Clausen, I. Förster, R. Pawlinski, N. Mackman, V. H. Haase, R. Jaenisch, M. Corr, V. Nizet, et al. 2003. HIF-1α is essential for myeloid cell-mediated inflammation. Cell 112:645-657.
2. Hara, T., K. Mimura, T. Abe, G. Shioi, M. Seiki, and T. Sakamoto. 2011. Deletion of the Mint3/Apba3 gene in mice abrogates macrophage functions and increases resistance to lipopolysaccharide-induced septic shock. J. Biol. Chem. 286:32542-32551.
3. Krawczyk, C. M., T. Holowka, J. Sun, J. Blagih, E. Amiel, R. J. De Berardinis, J. R. Cross, E. Jung, C. B. Thompson, R. G. Jones, and E. J. Pearce. 2010. Tolllike receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood 115:4742-4749.
4. Dietl, K., K. Renner, K. Dettmer, B. Timischl, K. Eberhart, C. Dorn, C. Hellerbrand, M. Kastenberger, L. A. Kunz-Schughart, P. J. Oefner, et al. 2010. Lactic acid and acidification inhibit TNF secretion and glycolysis of human monocytes. J. Immunol. 184:1200-1209.
5. Vats, D., L. Mukundan, J. I. Odegaard, L. Zhang, K. L. Smith, C. R. Morel, R. A. Wagner, D. R. Greaves, P. J. Murray, and A. Chawla. 2006. Oxidative metabolism and PGC-1β attenuate macrophage-mediated inflammation. Cell Metab. 4:13-24.
6. O'Neill, L. A. J., and D. G. Hardie. 2013. Metabolism of inflammation limited by AMPK and pseudo-starvation. Nature 493:346-355.
7. Liu, T. F., C. M. Brown, M. El Gazzar, L. McPhail, P. Millet, A. Rao, V. T. Vachharajani, B. K. Yoza, and C. E. McCall. 2012. Fueling the flame: bioenergy couples metabolism and inflammation. J. Leukoc. Biol. 92:499-507.
8. +-dependent sirtuin 1 and 6 proteins coordinate a switch from glucose to fatty acid oxidation during the acute inflammatory response. J. Biol. Chem. 287:25758-25769.
9. Dashty, M. 2013. A quick look at biochemistry: carbohydrate metabolism. Clin. Biochem. 46:1339-1352.
10. +-binding region (Rossmann fold). J. Biol. Chem. 270:2755-2763.
11. Caput, D., B. Beutler, K. Hartog, R. Thayer, S. Brown-Shimer, and A. Cerami. 1986. Identification of a common nucleotide sequence in the 39-untranslated region of mRNA molecules specifying inflammatory mediators. Proc. Natl. Acad. Sci. USA 83:1670-1674.
12. Chen, C. Y. A., and A. B. Shyu. 1995. AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem. Sci. 20:465-470.
13. Guhaniyogi, J., and G. Brewer. 2001. Regulation of mRNA stability in mammalian cells. Gene 265:11-23.
14. Rodríguez-Pascual, F., M. Redondo-Horcajo, N. Magán-Marchal, D. Lagares, A. Martínez-Ruiz, H. Kleinert, and S. Lamas. 2008. Glyceraldehyde-3-phosphate dehydrogenase regulates endothelin-1 expression by a novel, redoxsensitive mechanism involving mRNA stability. Mol. Cell. Biol. 28:7139-7155.
15. Chang, C. H., J. D. Curtis, L. B. Maggi, Jr., B. Faubert, A. V. Villarino, D. O'Sullivan, S. C. Huang, G. J. Van Der Windt, J. Blagih, J. Qiu, et al. 2013. Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell 153:1239-1251.
16. Hentze, M. W., and T. Preiss. 2010. The REM phase of gene regulation. Trends Biochem. Sci. 35:423-426.
17. El Gazzar, M., B. K. Yoza, J. Y. Hu, S. L. Cousart, and C. E. McCall. 2007. Epigenetic silencing of tumor necrosis factor a during endotoxin tolerance. J. Biol. Chem. 282:26857-26864.
18. Chen, X., M. El Gazzar, B. K. Yoza, and C. E. McCall. 2009. The NF-κB factor RelB and histone H3 lysine methyltransferase G9a directly interact to generate epigenetic silencing in endotoxin tolerance. J. Biol. Chem. 284:27857-27865.
19. McCall, C. E., B. Yoza, T. Liu, and M. El Gazzar. 2010. Gene-specific epigenetic regulation in serious infections with systemic inflammation. J. Innate Immun. 2:395-405.
20. Hoffmann, A., and D. Baltimore. 2006. Circuitry of nuclear factor κB signaling. Immunol. Rev. 210:171-186.
21. Beg, A. A., and D. Baltimore. 1996. An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274:782-784.
22. Chen, X., B. K. Yoza, M. El Gazzar, J. Y. Hu, S. L. Cousart, and C. E. McCall. 2009. RelB sustains IκBa expression during endotoxin tolerance. Clin. Vaccine Immunol. 16:104-110.
23. +-dependent SIRT1 deacetylase participates in epigenetic reprogramming during endotoxin tolerance. J. Biol. Chem. 286:9856-9864.
24. Zuckerman, S. H., and G. F. Evans. 1992. Endotoxin tolerance: in vivo regulation of tumor necrosis factor and interleukin-1 synthesis is at the transcriptional level. Cell. Immunol. 140:513-519.
25. El Gazzar, M., A. Church, T. Liu, and C. E. McCall. 2011. MicroRNA-146a regulates both transcription silencing and translation disruption of TNF-α during TLR4-induced gene reprogramming. J. Leukoc. Biol. 90:509-519.
26. El Gazzar, M., and C. E. McCall. 2010. MicroRNAs distinguish translational from transcriptional silencing during endotoxin tolerance. J. Biol. Chem. 285:20940-20951.
27. Zuckerman, S. H., G. F. Evans, and L. Guthrie. 1991. Transcriptional and posttranscriptional mechanisms involved in the differential expression of LPSinduced IL-1 and TNF mRNA. Immunology 73:460-465.
28. Lai, W. S., E. Carballo, J. R. Strum, E. A. Kennington, R. S. Phillips, and P. J. Blackshear. 1999. Evidence that tristetraprolin binds to AU-rich elements and promotes the deadenylation and destabilization of tumor necrosis factor a mRNA. Mol. Cell. Biol. 19:4311-4323.
29. Dan, C., B. Jinjun, H. Zi-Chun, M. Lin, C. Wei, Z. Xu, Z. Ri, C. Shun, S. Wen-Zhu, J. Qing-Cai, and Y. Wu. 2015. Modulation of TNF-α mRNA stability by human antigen R and miR181s in sepsis-induced immunoparalysis. EMBO Mol. Med. 7:140-157.
30. Carballo, E., W. S. Lai, and P. J. Blackshear. 1998. Feedback inhibition of macrophage tumor necrosis factor-α production by tristetraprolin. Science 281:1001-1005.
31. McCall, C. E., M. El Gazzar, T. Liu, V. Vachharajani, and B. Yoza. 2011. Epigenetics, bioenergetics, and microRNA coordinate gene-specific reprogramming during acute systemic inflammation. J. Leukoc. Biol. 90:439-446.
32. Khera, T. K., A. D. Dick, and L. B. Nicholson. 2010. Mechanisms of TNFα regulation in uveitis: focus on RNA-binding proteins. Prog. Retin. Eye Res. 29:610-621.
33. Le Goffe, C., G. Vallette, A. Jarry, C. Bou-Hanna, and C. L. Laboisse. 1999. The in vitro manipulation of carbohydrate metabolism: a new strategy for deciphering the cellular defence mechanisms against nitric oxide attack. Biochem. J. 344:643-648.
34. Yoza, B. K., J. D. Wells, and C. E. McCall. 1998. Interleukin-1β expression after inhibition of protein phosphatases in endotoxin-tolerant cells. Clin. Diagn. Lab. Immunol. 5:281-287.
35. Liu, T. F., V. Vachharajani, P. Millet, M. S. Bharadwaj, A. J. Molina, and C. E. McCall. 2015. Sequential actions of SIRT1-RELB-SIRT3 coordinate nuclear-mitochondrial communication during immunometabolic adaptation to acute inflammation and sepsis. J. Biol. Chem. 290:396-408.
36. Ferrick, D. A., A. Neilson, and C. Beeson. 2008. Advances in measuring cellular bioenergetics using extracellular flux. Drug Discov. Today 13:268-274.
37. Rogers, P. D., R. E. Kramer, S. W. Chapman, and J. D. Cleary. 1999. Amphotericin B-induced interleukin-1β expression in human monocytic cells is calcium and calmodulin dependent. J. Infect. Dis. 180:1259-1266.
38. Wolf, A., S. Agnihotri, J. Micallef, J. Mukherjee, N. Sabha, R. Cairns, C. Hawkins, and A. Guha. 2011. Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme. J. Exp. Med. 208:313-326.
39. Yates, S. L., L. H. Burgess, J. Kocsis-Angle, J. M. Antal, M. D. Dority, P. B. Embury, A. M. Piotrkowski, and K. R. Brunden. 2000. Amyloid b and amylin fibrils induce increases in proinflammatory cytokine and chemokine production by THP-1 cells and murine microglia. J. Neurochem. 74:1017-1025.
40. Kedzierski, W., and J. C. Porter. 1991. A novel non-enzymatic procedure for removing DNA template from RNA transcription mixtures. Biotechniques 10:210-214.
41. Moser, M. J., R. A. Di Francesco, K. Gowda, A. J. Klingele, D. R. Sugar, S. Stocki, D. A. Mead, and T. W. Schoenfeld. 2012. Thermostable DNA polymerase from a viral metagenome is a potent RT-PCR enzyme. PLoS One 7:e38371.
42. Tenenbaum, S. A., P. J. Lager, C. C. Carson, and J. D. Keene. 2002. Ribonomics: identifying mRNA subsets in mRNP complexes using antibodies to RNAbinding proteins and genomic arrays. Methods 26:191-198.
43. El Mezayen, R., M. El Gazzar, M. C. Seeds, C. E. McCall, S. C. Dreskin, and M. R. Nicolls. 2007. Endogenous signals released from necrotic cells augment inflammatory responses to bacterial endotoxin. Immunol. Lett. 111:36-44.
44. Gandin, V., K. Sikström, T. Alain, M. Morita, S. McLaughlan, O. Larsson, and I. Topisirovic. 2014. Polysome fractionation and analysis of mammalian translatomes on a genome-wide scale. J. Vis. Exp. (87):e51455.
45. Swerdlow, R. H., L. E, D. Aires, and J. Lu. 2013. Glycolysis-respiration relationships in a neuroblastoma cell line. Biochim. Biophys. Acta 1830:2891-2898.
46. Dott, W., P. Mistry, J. Wright, K. Cain, and K. E. Herbert. 2014. Modulation of mitochondrial bioenergetics in a skeletal muscle cell line model of mitochondrial toxicity. Redox Biol. 2:224-233.
47. Brueckmann, M., U. Hoffmann, L. De Rossi, H. M. Weiler, V. Liebe, S. Lang, J. J. Kaden, M. Borggrefe, K. K. Haase, and G. Huhle. 2004. Activated protein C inhibits the release of macrophage inflammatory protein-1-alpha from THP-1 cells and from human monocytes. Cytokine 26:106-113.
48. La Rue, K. E., and C. E. McCall. 1994. A labile transcriptional repressor modulates endotoxin tolerance. J. Exp. Med. 180:2269-2275.
49. Brundage, S. I., N. N. Kirilcuk, J. C. Lam, D. A. Spain, and N. A. Zautke. 2008. Insulin increases the release of proinflammatory mediators. J. Trauma 65:367-372.
50. Zhang, D., J. Li, F. Wang, J. Hu, S. Wang, and Y. Sun. 2014. 2-Deoxy-D-glucose targeting of glucose metabolism in cancer cells as a potential therapy. Cancer Lett. 355:176-183.
51. Dimitriadis, G., P. Mitrou, V. Lambadiari, E. Maratou, and S. A. Raptis. 2011. Insulin effects in muscle and adipose tissue. Diabetes Res. Clin. Pract. 93(Suppl. 1):S52-S59.
52. Thewissen, M. M., J. Van De Gaar, A. T. Den Boer, M. J. Munsters, E. E. Blaak, and A. Duijvestijn. 2014. Monocytes, but not T cells, respond to insulin with Akt (S473) phosphorylation independent of the donor glucometabolic state. Diabetes Metab. Res. Rev. 30:323-332.
53. Lardy, H. A. 1980. Antibiotic inhibitors of mitochondrial energy transfer. Pharmacol. Ther. 11:649-660.
54. McCall, C. E., and B. K. Yoza. 2007. Gene silencing in severe systemic inflammation. Am. J. Respir. Crit. Care Med. 175:763-767.
55. Bradley, J. R. 2008. TNF-mediated inflammatory disease. J. Pathol. 214:149-160.
56. Mills, E. L., and P. G. Quie. 1980. Congenital disorders of the function of polymorphonuclear neutrophils. Rev. Infect. Dis. 2:505-517.
57. Biswas, S. K., and E. Lopez-Collazo. 2009. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol. 30:475-487.
58. Monneret, G., F. Venet, A. Pachot, and A. Lepape. 2008. Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony. Mol. Med. 14:64-78.
59. Boomer, J. S., K. To, K. C. Chang, O. Takasu, D. F. Osborne, A. H. Walton, T. L. Bricker, S. D. Jarman, II, D. Kreisel, A. S. Krupnick, et al. 2011. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA 306:2594-2605.
60. Remick, D. G. 2003. Cytokine therapeutics for the treatment of sepsis: why has nothing worked? Curr. Pharm. Des. 9:75-82.
61. Pugin, J. 2007. Immunostimulation is a rational therapeutic strategy in sepsis. Novartis Found. Symp. 280:21-27.